Results 191 to 200 of about 56,752 (229)

Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial

Lancet, The, 2023
exaly  

Partial Nephrectomy

Urologia Internationalis, 1955
openaire   +2 more sources

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

Lancet, The, 2008
Christopher G Wood, Pramod K Srivastava, Louis Lacombe   +2 more
exaly  

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

New England Journal of Medicine, 2018
Alain Ravaud, Jean Baptiste Beauval, Antoine Thiery-vuillemin   +2 more
exaly  

Radical nephrectomy

Urology, 1995
openaire   +2 more sources

PARTIAL NEPHRECTOMY

Medical Journal of Australia, 1962
openaire   +2 more sources

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

New England Journal of Medicine, 2016
Alain Ravaud, Robert J Motzer, Daniel J George   +2 more
exaly  

Risk of chronic kidney disease after cancer nephrectomy

Nature Reviews Nephrology, 2014
Wei Ling Lau, Connie M Rhee, Csaba Kovesdy   +2 more
exaly  

Nephrectomy and Partial Nephrectomy

2013
openaire   +1 more source

Renal Cell Carcinoma Recurrence After Nephrectomy for Localized Disease: Predicting Survival From Time of Recurrence

Journal of Clinical Oncology, 2006
Scott E Eggener, Mark E Snyder, Robert J Motzer   +2 more
exaly